Angelo Ceci
24Patents
4h-index
25Co-inventors
59Inventor score
Filing activity: Jan 31, 2001 → Oct 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7291642B2 | Bradykinin-B1 antagonists, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 62 | Expired |
| US8785458B2 | Use of flibanserin in the treatment of obesity | Human Necessities | 12 | Active |
| US8227476B2 | Use of flibanserin in the treatment of obesity | Human Necessities | 12 | Active |
| US7923449B2 | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders | Human Necessities | 8 | Active |
| US8450306B2 | Bradykinin B1-receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US8372838B2 | Compounds as bradykinin B1 antagonists | Chemistry; Metallurgy | 3 | Active |
| US7858618B2 | Compounds | Chemistry; Metallurgy | 1 | Active |
| US7026475B2 | Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions | Human Necessities | 1 | Expired |
| US9730927B2 | Use of flibanserin in the treatment of obesity | Human Necessities | 1 | Active |
| US10849907B2 | Imidazopyridine derivatives and the use thereof as medicament | Chemistry; Metallurgy | 1 | Active |
| US6525045B2 | Positive allosteric AMPA receptor modulators | Human Necessities | 1 | Expired |
| US8252785B2 | Aryl sulfonamides as bradykinin-B1-receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11155539B2 | 4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament | Human Necessities | 0 | Active |
| US8916589B2 | Bradykinin B1-antagonists | Chemistry; Metallurgy | 0 | Active |
| US11104670B2 | 4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament | Human Necessities | 0 | Active |
| US10874668B2 | Use of Flibanserin in the treatment of obesity | Human Necessities | 0 | Active |
| US8937073B2 | Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8394805B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US11166958B2 | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | Human Necessities | 0 | Active |
| US10004731B2 | Flibanserin for the treatment of urinary incontinence and related diseases | Human Necessities | 0 | Active |
| US8865702B2 | B1-antagonists | Chemistry; Metallurgy | 0 | Active |
| US10335407B2 | Use of flibanserin in the treatment of obesity | Human Necessities | 0 | Active |
| US6800623B2 | Method of treating schizophrenia | Human Necessities | 0 | Expired |
| US9763936B2 | Flibanserin for the treatment of urinary incontinence and related diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.